Trials / Completed
CompletedNCT00237159
Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 284 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
It is the aim of this clinical study to evaluate the skeletal-related event rate and tolerability of zoledronic acid in patients with prostate cancer patients and bone metastases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zoledronic acid |
Timeline
- Start date
- 2002-10-01
- Primary completion
- 2005-12-01
- First posted
- 2005-10-12
- Last updated
- 2011-03-23
Source: ClinicalTrials.gov record NCT00237159. Inclusion in this directory is not an endorsement.